Investors with a lot of money to spend have taken a bearish stance on Hims & Hers Health HIMS.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HIMS, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 22 uncommon options trades for Hims & Hers Health.
This isn't normal.
The overall sentiment of these big-money traders is split between 31% bullish and 59%, bearish.
Out of all of the special options we uncovered, 8 are puts, for a total amount of $867,464, and 14 are calls, for a total amount of $1,137,344.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $20.0 to $55.0 for Hims & Hers Health over the recent three months.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Hims & Hers Health options trades today is 1558.53 with a total volume of 6,140.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Hims & Hers Health's big money trades within a strike price range of $20.0 to $55.0 over the last 30 days.
Hims & Hers Health Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | CALL | SWEEP | BULLISH | 07/18/25 | $11.15 | $10.5 | $11.15 | $32.00 | $559.9K | 588 | 500 |
| HIMS | PUT | SWEEP | BEARISH | 02/28/25 | $5.25 | $5.1 | $5.1 | $40.00 | $219.3K | 16 | 1.3K |
| HIMS | PUT | SWEEP | BULLISH | 02/28/25 | $5.25 | $5.1 | $5.1 | $40.00 | $147.9K | 16 | 1.3K |
| HIMS | PUT | TRADE | BEARISH | 02/28/25 | $5.1 | $4.45 | $5.1 | $40.00 | $139.7K | 16 | 882 |
| HIMS | PUT | TRADE | BEARISH | 02/07/25 | $2.3 | $2.1 | $2.3 | $37.00 | $138.0K | 4.2K | 58 |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
In light of the recent options history for Hims & Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of Hims & Hers Health
- Currently trading with a volume of 5,022,599, the HIMS's price is up by 1.72%, now at $37.92.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 21 days.
What The Experts Say On Hims & Hers Health
4 market experts have recently issued ratings for this stock, with a consensus target price of $28.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * In a cautious move, an analyst from Citigroup downgraded its rating to Sell, setting a price target of $25. * Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Hims & Hers Health, targeting a price of $24. * Consistent in their evaluation, an analyst from Needham keeps a Buy rating on Hims & Hers Health with a target price of $31. * In a cautious move, an analyst from BTIG downgraded its rating to Buy, setting a price target of $35.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Hims & Hers Health with Benzinga Pro for real-time alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
